The Trump administration has negotiated 15 deals in which pharmaceutical companies voluntarily agreed to lower prices on prescription medications in the United States.
The negotiations broke the longstanding practice by manufacturers of charging up to 400 percent more for brand-name drugs in the United States than in Canada, the United Kingdom, and other developed nations.
Dr. Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services, revealed the key tactic in these negotiations in an exclusive interview with Jan Jekielek, senior editor of The Epoch Times, due to air at 5 p.m. ET on Jan. 17.
“One of the most consequential things we’re doing involves the power to convene, pulling together people who normally wouldn’t talk with each other, to figure out action steps,” Dr. Oz said. …
Dr. Oz Explains How the Trump Admin Got Big Pharma to Voluntarily Lower Prices
